Aligos Therapeutics Inc. logo

Aligos Therapeutics Inc. (ALGS)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 08
0
0%
$
25.25M Market Cap
- P/E Ratio
- Div Yield
212,999 Volume
-10.36 Eps
$ 4.08
Previous Close
Analysts:
Add Transaction
Day Range
3.98 4.27
Year Range
3.98 13.69
Want to track ALGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
4 May 2026
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
9 Mar 2026
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
4 Nov 2025
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
5 Aug 2025
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
5 May 2025
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
10 Mar 2025
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
7 Mar 2024
-
-
Aligos Therapeutics Inc. logo
ALGS Aligos Therapeutics Inc.
31 Oct 2023
-
-

ALGS Earnings Reports FAQ

What is the earnings per share (EPS) for ALGS?

The current EPS is -10.36.

What is the company's earnings growth rate?

Aligos Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Aligos Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Aligos Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ALGS at this time, as Aligos Therapeutics Inc has no recent EPS data to calculate it.